Autoantibodies Could Help Predict Cancer Risk in Scleroderma

The autoantibodies anti-POLR3 and monospecific anti-Ro52 were associated with increased cancer risk, while anti-centromere and anti-U1RNP were tied to reduced risk.

Related Keywords

Pennsylvania , United States , Maryland , Baltimore , Johns Hopkins , Ji Soo Kim , Livia Casciola Rosen , University Of Pittsburgh Scleroderma Center , John Hopkins University , Johns Hopkins Scleroderma Center Research Registry , Pittsburgh Scleroderma Center , Soo Kim , Scleroderma , Crest Syndrome , Cancer Risk , Cancer , Alignant Neoplasia , Arcinoma , Arthritis , Oint Inflammation , Elisa , Enzyme Linked Immunosorbent Assay , Fellowship , Yellows ,